You just read:

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

News provided by

Prometheus Biosciences, Inc.

Oct 03, 2019, 18:14 ET